Elixinol Wellness Limited (EXL.AX)
AUD 0.04
(-7.5%)
AUD 0.04
(-7.5%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 178 Thousand AUD | -28.8% |
| 2022 | 250 Thousand AUD | 0.0% |
| 2021 | 250 Thousand AUD | 0.0% |
| 2020 | 250 Thousand AUD | -93.13% |
| 2019 | 3.64 Million AUD | 1356.4% |
| 2018 | 250 Thousand AUD | 0.0% |
| 2017 | 250 Thousand AUD | 2400.0% |
| 2016 | 10 Thousand AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 146 Thousand AUD | 0.0% |
| 2023 Q2 | 194 Thousand AUD | 0.0% |
| 2023 Q4 | 178 Thousand AUD | 0.0% |
| 2023 FY | 178 Thousand AUD | -28.8% |
| 2022 Q2 | 250 Thousand AUD | 0.0% |
| 2022 Q4 | 250 Thousand AUD | 0.0% |
| 2022 FY | 250 Thousand AUD | 0.0% |
| 2021 Q2 | 250 Thousand AUD | 0.0% |
| 2021 FY | 250 Thousand AUD | 0.0% |
| 2021 Q4 | 250 Thousand AUD | 0.0% |
| 2020 Q2 | 250 Thousand AUD | 0.0% |
| 2020 Q4 | 250 Thousand AUD | 0.0% |
| 2020 FY | 250 Thousand AUD | -93.13% |
| 2019 Q4 | 3.67 Million AUD | 0.0% |
| 2019 Q2 | 281 Thousand AUD | 0.0% |
| 2019 FY | 3.64 Million AUD | 1356.4% |
| 2018 Q4 | 250 Thousand AUD | 0.0% |
| 2018 Q2 | 250 Thousand AUD | 0.0% |
| 2018 FY | 250 Thousand AUD | 0.0% |
| 2017 FY | 250 Thousand AUD | 2400.0% |
| 2016 FY | 10 Thousand AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Althea Group Holdings Limited | - AUD | -Infinity% |
| Cann Group Limited | 421 Thousand AUD | 57.72% |
| ECS Botanics Holdings Ltd | - AUD | -Infinity% |
| Ecofibre Limited | 9.5 Million AUD | 98.126% |
| Hygrovest Limited | - AUD | -Infinity% |
| IDT Australia Limited | - AUD | -Infinity% |
| Invion Limited | - AUD | -Infinity% |
| Little Green Pharma Ltd | 5.31 Million AUD | 96.649% |
| Live Verdure Ltd | - AUD | -Infinity% |
| Medical Developments International Limited | 1.91 Million AUD | 90.705% |
| Vitura Health Limited | 4.11 Million AUD | 95.678% |
| Vita Life Sciences Limited | 176 Thousand AUD | -1.136% |